although
middl
east
respiratori
syndrom
coronaviru
merscov
record
year
circul
countri
worldwid
intern
studi
assess
whether
variat
mortal
region
neither
comprehens
studi
detail
diseas
characterist
merscov
influenc
mortal
patient
present
symptom
studi
aim
assess
region
patient
diseas
characterist
influenc
mortal
mer
patient
author
utilis
public
avail
data
merscov
studi
includ
mer
patient
report
januari
march
data
patient
diseas
characterist
collect
mean
age
merscov
diagnosi
year
male
case
report
saudi
arabia
mer
patient
studi
age
studi
estim
surviv
rate
initi
onset
symptom
respect
saudi
arabian
mer
patient
exhibit
time
higher
adjust
hazard
risk
ahr
confid
interv
ci
ahr
ci
mortal
risk
compar
mer
patient
republ
korea
countri
similarli
middl
eastern
mer
patient
show
time
higher
ahr
ci
ahr
ci
mortal
risk
compar
mer
patient
republ
korea
countri
result
demonstr
link
mortal
geographi
diseas
patient
factor
region
symptom
sourc
infect
underli
medic
condit
mode
transmiss
nonhealthcar
worker
older
age
educ
programm
access
healthcar
earli
diagnosi
could
implement
modifi
factor
reduc
higher
mortal
rate
mer
patient
middl
east
respiratori
syndrom
coronaviru
merscov
intern
public
health
challeng
consider
differ
method
report
deathrel
within
countri
case
fatal
rate
account
saudi
arabia
republ
korea
recent
sever
epidemiolog
investig
publish
assess
factor
associ
mortal
mer
patient
howev
find
studi
either
repres
specif
popul
group
intens
care
unit
singl
medic
centr
outbreak
infect
republ
korea
one
studi
analys
publicli
avail
data
saudi
ministri
health
webpag
identifi
factor
associ
mortal
saudi
arabian
patient
one
limit
studi
lack
multivari
risk
model
river
et
al
use
multivari
poisson
regress
model
identifi
factor
associ
high
incid
mortal
studi
exclud
case
republ
korea
recent
studi
chen
et
al
compar
risk
factor
diseas
characterist
south
korean
saudi
arabian
popul
assess
surviv
rate
case
author
previous
publish
studi
merscov
abl
assess
surviv
rate
mer
case
variou
countri
report
world
health
organ
although
mention
studi
provid
valuabl
inform
term
mortal
risk
mer
patient
common
limit
note
previou
studi
global
data
use
associ
differ
geograph
region
mortal
find
report
made
use
data
specif
popul
region
per
author
knowledg
time
larg
crosscountri
comparison
studi
merscovrel
mortal
yet
clear
whether
mortal
rate
merscov
identifi
countri
region
import
understand
compar
merscov
patient
accord
clinic
outcom
multicountri
studi
may
provid
use
multicountri
work
reduc
mortal
merscov
popul
worldwid
current
studi
may
provid
multivari
risk
model
identifi
patient
high
risk
death
order
manag
merscov
patient
clinic
outcom
may
improv
public
health
plan
establish
effect
programm
prevent
seriou
outcom
programm
address
healthcar
system
public
health
polici
goal
studi
estim
compar
variat
riskstandardis
mortal
rate
region
patient
characterist
among
differ
countri
across
world
specif
compar
region
largest
number
merscov
case
author
hypothesis
peopl
older
age
underli
medic
condit
saudi
arabia
middl
east
countri
high
risk
death
relat
merscov
studi
utilis
publicli
avail
merscov
databas
case
report
retriev
http
wwwwhoint
csrdonarchivediseasecoronavirusinfectionsen
receiv
situat
report
confirm
merscov
case
countri
across
globe
provid
routin
updat
websit
new
case
death
current
develop
prior
januari
report
present
narr
format
describ
case
case
diseas
characterist
patient
author
research
assist
access
narr
report
convert
patient
inform
diseas
characterist
line
list
analysi
begin
report
period
januari
enhanc
report
practic
includ
excel
document
patient
diseas
characterist
data
easili
analys
latest
line
list
updat
mer
case
april
report
qatar
global
report
april
indic
overal
case
fatal
rate
death
cumul
laboratoryconfirm
mer
case
countri
author
includ
mer
case
report
earli
report
mer
use
unstandardis
case
present
lack
import
detail
studi
includ
mer
case
report
januari
march
anoth
reason
choos
period
studi
start
report
case
countri
confirm
case
occur
author
perform
qualiti
control
check
detect
invalid
miss
data
author
exclud
case
republ
korea
report
june
juli
patient
case
report
use
report
summari
updat
case
total
case
death
instead
casebycas
detail
case
report
march
exclud
saudi
arabia
due
wrong
date
symptom
onset
state
case
report
total
case
includ
analysi
author
obtain
inform
age
gender
date
notif
date
onset
mer
symptom
date
outcom
death
whether
patient
healthcar
worker
symptomat
underli
medic
condit
sourc
infect
report
countri
order
assess
impact
older
age
mortal
among
mer
patient
patient
age
classifi
four
group
age
year
data
retriev
countri
author
classifi
countri
three
region
accord
geograph
locat
number
case
saudi
arabia
middl
east
exclud
saudi
arabia
republ
korea
countri
republ
korea
countri
combin
due
small
number
case
latter
group
saudi
arabia
analys
separ
middl
east
countri
saudi
arabia
uniqu
situat
record
largest
number
mer
case
two
primari
end
point
assess
mortal
relat
mersaft
develop
symptom
studi
author
estim
surviv
rate
use
time
symptom
onset
outcom
merscov
incub
period
day
time
symptom
usual
occur
surviv
rate
mark
medic
signific
demonstr
surviv
point
patient
typic
experi
statist
analys
perform
sa
version
softwar
data
merscov
patient
report
januari
march
retriev
analys
descript
statist
use
describ
studi
popul
tabl
unadjust
cox
proport
hazard
model
cphm
use
estim
hazard
risk
hr
confid
interv
ci
mortal
tabl
multivari
cphm
use
estim
adjust
hazard
risk
ahr
ci
mortal
adjust
gender
age
region
whether
healthcar
worker
comorbid
asymptomat
sourc
infect
tabl
logrank
test
use
compar
surviv
curv
demograph
diseas
characterist
fig
surviv
rate
estim
use
kaplanmei
estim
total
patient
confirm
merscov
infect
includ
analysi
characterist
popul
found
tabl
illustr
unadjust
adjust
hazard
risk
allcaus
mortal
unadjust
analysi
show
age
group
year
saudi
arabia
studi
conduct
estim
surviv
rate
mer
patient
specif
day
experienc
merscov
symptom
determin
whether
signific
epidemiolog
infect
differ
surviv
rate
demograph
data
diseas
characterist
region
use
global
mer
data
report
author
use
cphm
kaplanmei
estim
calcul
surviv
rate
accord
data
estim
overal
surviv
rate
ci
studi
estim
surviv
rate
ci
ci
respect
author
calcul
regionspecif
surviv
rate
fig
mer
patient
studi
republ
korea
countri
much
higher
surviv
rate
middl
east
saudi
arabia
respect
differ
regionspecif
surviv
rate
remain
signific
account
patient
diseas
factor
gender
age
comorbid
symptom
healthcar
worker
sourc
infect
instanc
hazard
death
postsymptom
time
higher
middl
east
saudi
arabia
compar
republ
korea
countri
respect
dispar
surviv
rate
region
probabl
explain
delay
report
mer
symptom
consequ
delay
diagnosi
median
time
date
onset
symptom
death
lower
republ
korea
countri
middl
east
saudi
arabia
research
studi
requir
assess
whether
diagnost
delay
diseas
characterist
explain
differ
surviv
rate
geograph
region
age
year
older
repres
larg
portion
mer
popul
predominantli
contribut
high
portion
death
well
find
studi
show
surviv
rate
tend
rise
increas
age
fig
similar
women
compar
men
estim
surviv
rate
patient
older
year
patient
age
year
patient
age
year
young
patient
age
year
less
result
support
variou
epidemiolog
cohort
saudi
arabia
republ
korea
state
older
age
risk
factor
death
mer
patient
high
death
rate
among
older
age
group
could
attribut
greater
number
patient
comorbid
group
preval
comorbid
increas
age
young
age
group
year
year
year
older
year
thu
comorbid
may
associ
age
mortal
sever
studi
includ
current
studi
suggest
presenc
underli
condit
associ
increas
hazard
death
mer
patient
detail
underli
condit
need
estim
underli
conditionspecif
surviv
rate
would
use
identifi
underli
condit
associ
lower
surviv
rate
moreov
prevent
diseas
manag
strategi
assess
intervent
mer
patient
underli
condit
reduc
mortal
rate
group
concord
studi
nonhealthcar
worker
associ
lower
surviv
rate
fig
studi
includ
healthcar
worker
five
die
higher
surviv
rate
within
healthcar
worker
group
could
attribut
educ
healthcar
worker
prepared
access
healthcar
follow
proper
infect
control
standard
explan
lower
surviv
rate
nonhealthcar
worker
group
larg
gap
public
awar
clinic
symptom
merscov
public
health
health
system
intervent
need
reduc
spread
mer
rais
public
awar
identifi
clinic
symptom
earli
screen
diagnosi
could
reduc
high
rate
mortal
nonhealthcar
worker
patient
acquir
infect
camel
hospit
unknown
sourc
infect
exhibit
time
higher
mortal
risk
compar
patient
acquir
infect
household
member
respect
fig
healthcar
system
may
use
inform
properli
develop
support
care
plan
improv
patient
outcom
anwar
e
ahm
studi
sever
limit
studi
use
avail
data
public
sourc
detail
underli
condit
inform
could
import
identifi
underli
condit
associ
death
patient
condit
clinic
outcom
may
final
data
updat
routin
anoth
potenti
confound
factor
avail
access
healthcar
may
consid
modifi
factor
account
final
inverseprob
kaplanmei
curv
may
also
appropri
model
dataset
may
provid
perspect
data
visual
way
show
adjust
surviv
rate
despit
limit
studi
author
abl
use
estim
surviv
rate
measur
time
symptom
onset
outcom
date
studi
provid
surviv
estim
link
region
studi
provid
inform
regionspecif
surviv
rate
found
account
differ
mortal
larg
sampl
size
use
also
main
strength
studi
futur
studi
could
investig
diagnost
delay
defin
differ
date
symptom
onset
time
diagnosi
may
reduc
poor
outcom
studi
estim
surviv
rate
initi
onset
symptom
respect
result
demonstr
link
mortal
geographi
diseas
patient
factor
region
symptom
sourc
infect
underli
medic
condit
mode
transmiss
nonhealthcar
worker
older
age
educ
programm
access
healthcar
earli
diagnosi
could
implement
modifi
factor
reduc
higher
mortal
rate
mer
patient
addit
file
none
ethic
approv
consent
particip
applic
consent
public
author
read
approv
final
manuscript
avail
support
data
data
use
analysi
obtain
studi
author
declar
interest
none
declar
